CNDP1

Chr 18

carnosine dipeptidase 1

Also known as: CN1, CPGL2, HsT2308

This protein is a brain-specific dipeptidase that hydrolyzes carnosine and other histidine-containing dipeptides. Mutations cause carnosinase deficiency, an autosomal recessive disorder characterized by elevated carnosine levels in urine and cerebrospinal fluid, typically presenting with developmental delay, intellectual disability, and seizures in early childhood. The gene is highly tolerant to loss-of-function variation in the general population.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
153
P/LP submissions
0%
P/LP missense
1.00
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCNDP1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
151 unique Pathogenic / Likely Pathogenic· 93 VUS of 272 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.00LOEUF
pLI 0.000
Z-score 1.55
OE 0.68 (0.471.00)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.42Z-score
OE missense 0.93 (0.851.03)
291 obs / 311.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.68 (0.471.00)
00.351.4
Missense OE0.93 (0.851.03)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 18 / 26.6Missense obs/exp: 291 / 311.8Syn Z: -0.40
DN
0.7130th %ile
GOF
0.7125th %ile
LOF
0.2288th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

272 submitted variants in ClinVar

Classification Summary

Pathogenic145
Likely Pathogenic6
VUS93
Likely Benign17
Benign6
145
Pathogenic
6
Likely Pathogenic
93
VUS
17
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
145
0
145
Likely Pathogenic
0
0
6
0
6
VUS
0
72
21
0
93
Likely Benign
1
13
2
1
17
Benign
0
4
2
0
6
Total1891761267

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CNDP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →